Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970007 · ClinicalTrials.gov registry record · NA
VIVO Clinical Study
A NA study of Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 243
- Enrollment target
- 20
- Study locations
NCT01970007: Completed NA study of Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein, sponsored by Cook Research Incorporated.
NCT01970007 is a NA study of Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein that has completed, run by Cook Research Incorporated. The registered enrollment target is 243 participants. The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01970007, a NA study of Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.
Conditions Studied
Interventions
- DEVICE Zilver Vena Venous Self-Expanding Stent
Study Locations (20)
Connecticut
- Yale-New Haven Hospital - New Haven
- Southern Connecticut Vascular Center - Norwalk Hospital - Norwalk
Indiana
- Methodist Hospital of Indiana - Indianapolis
- St. Vincent Medical Group - Indianapolis
Missouri
- Barnes Jewish Hospital Plaza - St Louis
- Mercy Hospital - St Louis
Alabama
- University of Alabama Birmingham Hospital - Birmingham
Arizona
- Arrowhead Hospital - Glendale
Colorado
- Littleton Adventist Hospital - Littleton
Delaware
- Christiana Care Health Systems - Newark
Florida
- Florida Pepin Heart Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2013-12-13 |
| Est. Completion | 2019-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01970007
The ClinicalTrials.gov registry entry for NCT01970007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein appearing as the primary indexed condition, and to 1 intervention - of which Zilver Vena Venous Self-Expanding Stent is the first listed.
NCT01970007 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Connecticut, Indiana, Missouri.
Frequently Asked Questions
What is clinical trial NCT01970007 about?
NCT01970007 is a clinical study titled "VIVO Clinical Study". The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.
What is the current status of trial NCT01970007?
This trial is currently completed. It is a NA study. The enrollment target is 243 participants. The study started on 2013-12-13. Estimated completion is 2019-11-20.
What conditions does trial NCT01970007 study?
This clinical trial studies the following conditions: Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein.
What interventions are being tested in trial NCT01970007?
The interventions under investigation include: Zilver Vena Venous Self-Expanding Stent (DEVICE).
Who is sponsoring clinical trial NCT01970007?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01970007 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.